Dr. Barry Dworkin

Injectable medication might help specific populations reach heart disease prevention targets

Madely Health Headlines Commentary for March 27, 2012

 

 

Source:

New Injection Might Lower Tough-to-Treat Cholesterol

Reference:

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

Related posts:

  1. Test may help predict imminent heart attack
  2. Silent atrial fibrillation a cause for strokes:study
  3. Study unable to show causation for increased stroke risk in first month of warfarin treatment for patients with atrial fibrillation
  4. Biological mechanisms remain hypothetical to explain why observational study finds brushing your teeth three times a day reduces your risk of atrial fibrillation and congestive heart failure.